Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease disseminated intravascular coagulation
Phenotype C0023418|leukemia
Sentences 9
PubMedID- 24217998 Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment using recombinant human soluble thrombomodulin.
PubMedID- 23559733 [1–3] disseminated intravascular coagulation also occurs in patients with leukemia due to hypofibrinogenemia.
PubMedID- 23943008 The occurrence of hyperleukocytosis (leukocytes > 100.000/mul) is associated with complications such as leukostasis, tumor lysis and consumption coagulopathy in patients with acute leukemia much more often than in patients with chronic malignant hematological diseases.
PubMedID- 19500934 Background: hyperleukocytosis in acute leukemia is associated with lymphadenopathy, hepatosplenomegaly, disseminated intravascular coagulation, and central nervous system complications.
PubMedID- 25934464 Recombinant human thrombomodulin in the treatment of acute myeloid leukemia patients complicated by disseminated intravascular coagulation: retrospective analysis of outcomes between patients treated with heparin and recombinant human thrombomodulin therapy.
PubMedID- 24762998 This study was aimed to explore the clinical characteristics and optimal therapeutic methods for newly diagnosed acute promyelocytic leukemia (apl) combined with disseminated intravascular coagulation (dic) so as to guide the clinical therapy.
PubMedID- 25759668 We recently evaluated and performed vitrectomy in a child with severe massive vitreous hemorrhage due to secondary acute myelogenous leukemia (aml) associated with disseminated intravascular coagulation (dic) and tumor lysis syndrome.
PubMedID- 22044440 Case presentation: a 9 year-old male with acute lymphoblastic leukemia complicated by pancytopenia and disseminated intravascular coagulation was given platelet transfusion.
PubMedID- 23291674 Clinical features and treatment outcomes of six patients with disseminated intravascular coagulation resulting from acute promyelocytic leukemia and treated with recombinant human soluble thrombomodulin at a single institution.

Page: 1